Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sheng-Tai Tzeng"'
Autor:
Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, Ming-Chih Ho, Chi-Ling Chen, Tung-Ching Ho, Yung-Feng Lin, Shih-Feng Tsai, Sheng-Tai Tzeng, Chin-Fang Huang, Ya-Chun Wang, Shiou-Hwei Yeh, Pei-Jer Chen
Publikováno v:
Liver Cancer (2023)
Introduction: A set of genetic mutations to classify hepatocellular carcinoma (HCC) useful to clinical studies is an unmet need. Hepatitis B virus-related HCC (HBV-HCC) harbors a unique genetic mutation, namely the HBV integration, among other somati
Externí odkaz:
https://doaj.org/article/031608ce259b4f12ae2bc4141f930896
Autor:
Sheng-Tai Tzeng, Ming-Hong Tsai, Chi-Long Chen, Jing-Xing Lee, Tzu-Ming Jao, Sung-Liang Yu, Sou-Jhy Yen, Ya-Chien Yang
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67040 (2013)
BACKGROUND: Genomic deletion at tumor suppressor loci is a common genetic aberration in human cancers. The study aimed to explore candidate tumor suppressor genes at chromosome 4q25-q28.2 and to delineate novel prognostic biomarkers associated with c
Externí odkaz:
https://doaj.org/article/ef4a64ca7baa452594d5e46d95fc885b
Autor:
Sheng-Tai Tzeng, 曾晟泰
101
Colorectal cancer (CRC) is one of the most common causes of cancer deaths in the world, and most of CRC arise sporadically by the emergence of multiple chromosomal aberrations. Allelic losses in the long arm of chromosome 4 are commonly enco
Colorectal cancer (CRC) is one of the most common causes of cancer deaths in the world, and most of CRC arise sporadically by the emergence of multiple chromosomal aberrations. Allelic losses in the long arm of chromosome 4 are commonly enco
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/98338703389971702389
Autor:
Sheng-Tai Tzeng, 曾聖太
93
In recent years,mobile ad hoc network has become a widely used technology which is based on IEEE 802.11 standards.First,we study FCR(FAST COLLISION RESULOTION and compare with DCF(Distributed Coordination Function). Recently,more and more att
In recent years,mobile ad hoc network has become a widely used technology which is based on IEEE 802.11 standards.First,we study FCR(FAST COLLISION RESULOTION and compare with DCF(Distributed Coordination Function). Recently,more and more att
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/79208171972149136938
Autor:
Ming-Chih Ho, Shiou-Hwei Yeh, Chi-Ling Chen, Sheng-Tai Tzeng, Yu-Hsin Lee, Ding-Shinn Chen, Yun-Ju Chen, Ya-Chun Wang, Chiao-Ling Li, You-Yu Lin, Hsin-Yung Pai, Pei-Jer Chen
Publikováno v:
Hepatology (Baltimore, Md.)References. 72(6)
BACKGROUND AND AIMS Early recurrence of hepatocellular carcinoma (HCC) after surgical resection compromises patient survival. Timely detection of HCC recurrence and its clonality is required to implement salvage therapies appropriately. This study ex
Autor:
Sheng-Tai Tzeng, Chiao-Ling Li, Ya-Chun Wang, Hsin-Yung Pai, You-Yu Lin, Shiou-Hwei Yeh, Ming-Chih Ho, Pei-Jer Chen, Yun-Ju Chen
Publikováno v:
Journal of Hepatology. 70:e852-e853
Autor:
Sou-Jhy Yen, Ya-Chien Yang, Sheng-Tai Tzeng, Chun-Chieh Chen, Sung-Liang Yu, Wen-Chi Chen, Tzu-Ming Jao, Ming-Hong Tsai, Chi-Yen Huang
Publikováno v:
Annals of Surgical Oncology. 22:1481-1489
Shisa3 is a novel tumor suppressor identified in lung cancer. However, its antitumor activity in other human cancers and the mechanism of gene inactivation remain unknown. SHISA3 expression was measured by reverse transcription-PCR (RT-PCR) and quant
Autor:
Sou-Jhy Yen, Tzu-Ming Jao, Chun-Chieh Chen, Ya-Chien Yang, Wei-Ting Weng, Yen-Chun Lai, Ming-Hong Tsai, Hoi-Yan Lio, Chia-Yun Chang, Sheng-Tai Tzeng, Sung-Liang Yu
Publikováno v:
International Journal of Cancer. 135:2593-2603
Protocadherin 10 (PCDH10), a novel tumor suppressor gene in human cancers, is located in a common deleted region at chromosome 4q28 in colorectal cancer (CRC). This study aimed to ascertain the genetic loss of PCDH10 and its clinical relevance in CRC
Autor:
Sheng-Tai Tzeng, Yun-Ju Chen, Hsin-Yung Pai, Ming-Chih Ho, Chiao-Ling Li, You-Yu Lin, Ya-Chun Wang, Shiou-Hwei Yeh, Pei-Jer Chen
Publikováno v:
Journal of Clinical Oncology. 37:4090-4090
4090 Background: About one-third of patients suffer tumor recurrence within the first year after surgical resection of HCC. Early recurrence compromised their overall survival. Timing detection of HCC recurrence and its clonality is required to imple